MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202541002616 A) filed by Stereokem Pharmaceuticals Pvt. Ltd on January 11, 2025, for Improved Process For The Prepration Of A Gliptin And Its Precursors.
Inventors include Venkateshwar Kumar Thaduri; Venugopala Rao Bandi; Ravisankar Vamaraju; Jeongseok Han; and Philgoo Kang.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: ABSTRACT IMPROVED PROCESS FOR THE PREPRATION OF A GLIPTIN DERIVATIVE The present invention relates to an improved process for the preparation of dipeptidyl peptidase-4 inhibitor used in the treatment of type 2 diabetes. The present invention also relates to an improved process for the preparation of intermediates of compound of formula (II) used in the preparation of a gliptin.
Disclaimer: Curated by HT Syndication.